Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Autologous EPCs for Diabetic Foot With Infrapopliteal Arterial Stenosis/Occlusion
NCT02474381Unknown
- Sponsor
- Shanghai Tenth People's Hospital
- Start
- Dec 2012
- Primary completion
- Nov 2016
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
Open-label trial of autologous CD133+ cells in diabetic foot disease (DFD) and Peripheral Arterial Disease (PAD) (2 arms), sponsored by Shanghai Tenth People's Hospital. Primary endpoints: Infrapopliteal arterial patency of the affected extremity at 12 months and Aggravation of ulcer at 18 months. Status: unknown.
02
Drugs
autologous CD133+ cells
03
Conditions
diabetic foot disease (DFD)Peripheral Arterial Disease (PAD)
Beyond the preview
Go deeper on NCT02474381.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02474381.